Twelve infants, median gestational age 27 weeks and postnatal age 1 day, were examined to determine whether oxygenation improves on transfer to high frequency oscillation (HFO). Lung volume was assessed before transfer to HFO by measuring functional residual capacity (FRC) using a helium gas dilution technique and specially designed infant circuit. On transfer to HFO, the inspired oxygen was initially kept constant, but the mean airway pressure (MAP) increased until maximum oxygenation was achieved (optimal MAP). The median FRC of the 12 infants before HFO was 8-1 ml/kg (range 4*7 to 28.7) and their median alveolararterial oxygen gradient (A-aDO2) 484 mm Hg. On transfer to HFO, oxygenation did not improve in two infants, but, overall, the A-aDO2 fell to a median of 289 mm Hg (p<005). The median optimal MAP was 18-5 cm H20 (range 106 to 24.4) and this had an inverse correlation with the Transfer to high frequency oscillation (HFO) can improve oxygenation in infants whose respiratory failure has responded poorly to conventional ventilation.' When a 'high volume' strategy is pursued the improvements in oxygenation seen when the mean airway pressure (MAP) is increased may be attributable to the opening up of atelectatic lungs and the maintenance of the lung above its closing volume.2 If that supposition is correct then infants with the lowest lung volume would require the greatest increase in MAP to optimise oxygenation. To test that hypothesis we assessed lung volume by measuring functional residual capacity (FRC) before transfer to HFO and related this to the absolute and change in MAP level necessary to maximise oxygenation.
Transfer to high frequency oscillation (HFO) can improve oxygenation in infants whose respiratory failure has responded poorly to conventional ventilation.' When a 'high volume' strategy is pursued the improvements in oxygenation seen when the mean airway pressure (MAP) is increased may be attributable to the opening up of atelectatic lungs and the maintenance of the lung above its closing volume.2 If that supposition is correct then infants with the lowest lung volume would require the greatest increase in MAP to optimise oxygenation. To test that hypothesis we assessed lung volume by measuring functional residual capacity (FRC) before transfer to HFO and related this to the absolute and change in MAP level necessary to maximise oxygenation.
Methods
Infants were transferred to HFO if their respiratory failure was deemed by the clinician in charge to be responding poorly to conventional ventilation. This was defined as a requirement for an inspired oxygen concentration (FIO2) of 0-5 or greater and/or a MAP of at least 10 cm H20 to maintain the pH between 7-25 and 7 40, arterial oxygen tension (Pao2) between 6-67 and 12-0 kPa (50 and 90 mm Hg), and arterial carbon dioxide tension (Paco2) between 4-67 and 6-67 kPa (35 and 50 mm Hg). Their respiratory status was confirmed by measuring a blood sample taken from an indwelling arterial line sited for clinical purposes.
Immediately before transfer to HFO, FRC was estimated twice in each infant, with an interval of 10 minutes between measurements. Infants were measured in a supine position. A helium gas dilution technique and specially designed infant circuit with a circuit volume of 95 ml was used.3 The measurement technique has been described in detail before.4 The FRC system contains a rebreathing bag -the system reservoir -enclosed in an airtight cylinder. During measurement, the infant's endotracheal tube is connected to the rebreathing bag via a three-way valve. The ventilator is also connected to the three-way valve and the valve is connected to a side port on the airway cylinder. The infant can therefore be ventilated directly or, once the position of the three-way valve is changed, to breathe from the rebreathing bag whilst receiving positive pressure support by changes in pressure within the cylinder, resulting in compression of the rebreathing bag. The helium analyser (Equilibrated Biosystems) has a digital display which was recorded before and at 15 second intervals during the measurement. Equilibration was assumed when there was similar helium concentration over a 30 second interval. The initial and equilibration helium concentrations were used in the calculation of FRC. FRC results were corrected for oxygen consumption, assumed to be 7 reached. If no change in Pao2 had occurred then the settings remained unchanged for 30 minutes. If after that time there was still no improvement in Pao2 (confirmed by an arterial blood gas sample), the MAP was reduced by 2 cm H20 increments until the MAP on conventional ventilation was reached. If during that period and after a further 30 minutes there was no increase in oxygenation, again confirmed by arterial blood gas sampling, the infant was subsequently returned to conventional ventilation. The optimal MAP under these circumstances was deemed that of conventional ventilation (the change in MAP being zero). If the Pao2 had improved as the MAP was being increased an increase in MAP continued until no further improvement was experienced, and that level was then maintained for 30 minutes. If there was no further change in oxygenation, confirmed by arterial blood gas sampling, that MAP level was designated optimal. If, however, oxygenation further improved, MAP was again increased until the maximum Pao2 had been reached. If at any stage there was a deterioration in oxygenation the infant was returned to the MAP level immediately below.
Throughout the study, the infants were continuously monitored using both transcutaneous oxygen monitoring and oxygen saturation. Some infants also had intra-arterial Pao2 electrodes, and all had indwelling arterial catheters. If, at any time, the continuous monitoring showed that the infant's Pao2 was greater than 12-0 kPa (90 mm Hg), then the inspired oxygen concentration was appropniately reduced. The optimal MAP was defined as that at which maximum oxygenation was experienced, demonstrated by continuous monitoring and confirmed by arterial blood sampling. Alveolar-arterial oxygen gradients (A-aDO2) were calculated from the arterial blood gases taken immediately before transfer to HFO and at the optimal MAP level. The A-aDO2 was calculated according to the following formula:
[Barometric-water vapour pressureXFio,-Paco,-Pao,] (mm Hg) Barometric pressure=760 mm Hg; water vapour pressure=47 mm Hg.
Once the optimal MAP had been established, as is our usual clinical practice, a chest radiograph was performed to assess whether there was evidence of hyperinflation. This was diagnosed by thinning of the cardiac silhouette, flattening of the diaphragms, and exposure of more than eight posterior ribs.
The coefficient of repeatability of the FRC measurement was calculated according to the method of Bland and Altman (fig 1).6 The difference between paired measurements was calculated for each individual. The sum of these differences squared was divided by the number of subjects, the square root of the result being the standard deviation of the differences. Twice this standard deviation gave the coefficient of repeatability.
The optimal MAP level was that at which maximum oxygenation was achieved. The change in MAP necessary to maximise oxygenation was calculated by subtracting the MAP level on conventional ventilation from the optimal MAP level. Differences between groups were assessed for significance using the Wilcoxon signed rank test. Correlations between FRC and the optimum MAP or change in MAP were assessed for significance by calculation of Spearman's rank correlation coefficients.
Twelve infants were included in the study; their diagnoses were respiratory distress syndrome (RDS) (n=6), meconium aspiration syndrome (MAS) (n=4), congenital pneumonia (n= 1) and pulmonary haemorrhage (n= 1). Their median gestational age was 26-5 weeks (range 23-42), birthweight 0907 kg (0-536-4.296), and postnatal age 1 day (1-3).
The infants were initially ventilated using Sechrist IV ventilators (Sechrist Industries Inc), and oral shouldered endotracheal tubes.
Immediately before transfer to HFO the infants were receiving a median peak inspiratory pressure of 24-5 cm H20 (range 17-41), a MAP of 111 cm H20 (7-90-17-60) , and an FiO2 of 08 (048-1-0). At the time of transfer the infants' median A-aDO2 was 484 mm Hg (range 240-626). Nine infants had received surfactant (six who had RDS and three infants with MAS). Except for one infant with MAS who received a natural surfactant (Survanta), an artificial surfactant (Exosurf) was used. All the measurements of FRC were made at least one hour after surfactant had been given, a median time of two hours (range one to 12). The infant given Survanta was studied after one hour.
Results
The median FRC before transfer was 8-1 ml/kg (range [4] [5] [6] [7] to 28-7). The equilibration time was in a median of 30 seconds (range 30-60). The mean difference in FRC between an individual's paired measurements was 0-14 ml/kg (range -7 30 to 4 13 ml/kg), standard deviation (SD) of the differences being (fig 1) . MAP on conventional ventilation, compared with HFO, could achieve the same results, this would be more likely to increase complications as a result of barotrauma. An increase in MAP to improve oxygenation, however, is only relevant when the lung volume is low. In animals with healthy lungs, a change in the MAP level by modest amounts does not affect gas exchange,8 9 whereas a large increase in MAP resulted in a deterioration in blood gases due to lung overdistension.10 Thus it is not surprising that in this series the two infants with MAS who had relatively high lung volumes did not improve on HFO when MAP was increased.
Infants were left at each MAP setting only for 10 minutes. We did not expect the maximum change in oxygenation after such a short period of time but it was our clinical experience11 that if oxygenation would improve in response to an increase in MAP, a change, as documented by continuous monitoring, would have at least started to occur by 10 minutes. By allowing only 10 minutes at each MAP change, this facilitated the arrival of the infant at the optimal MAP level in the shortest time period. At the optimal level we then deliberately checked the arterial blood gas level after only 30 minutes, as we had already found such a time period sufficient for the maximum change in Pao2 to be experienced.1
Nine of the 12 infants were studied after surfactant administration. Exogenous surfactant replacement used during conventional ventilation affects oxygenation. The timing of the effect, however, is variable. 12 Cotton et al noted a significant change only two hours after an artificial surfactant, but after 30 minutes with a natural surfactant.12 We therefore do not feel that the changes in oxygenation our infants experienced can be explained by the surfactant administration. Firstly, four were studied 60 minutes after receiving an artificial surfactant and thus would not be expected'2 at that time to be experiencing an improvement in oxygenation. Secondly, a fifth infant, who had MAS and received surfactant, had no change in oxygenation on transfer to HFO. Thirdly, changes in oxygenation in response to MAP increases also occurred in infants not treated with surfactant. Lastly, the changes in Pao2 occurred within 10 minutes of a change in the MAP level and this response was seen repeatedly in most infants. We thus feel the improvements in oxygenation were as a consequence of the transfer to HFO and the high volume strategy pursued.
To measure FRC a low volume infant circuit was used. In most of the infants the two separate measurements yielded similar data (fig 1) . Indeed there was only one infant in whom there was major discrepancy between the two results. Exclusion of that one outlier gave a coefficient of repeatability as low as 3.5 mllkg. The coefficient of repeatability in the ventilated infants was lower than that experienced in non-ventilated infants using either the same helium circuit or a nitrogen washout technique.4 All the infants were ventilated with shouldered endotracheal tubes.
Previous measurements of tidal volume using such tubes have shown little evidence of leak, with minimal or no differences between the inspiratory and expiratory volumes. ' 3 The values of FRC were within the ranges reported before. 1417 We had found before that it was not possible to identify before HFO those infants who would benefit from that mode of respiratory support by either their MAP level or A-aDO2. 11 In the present study, however, oxygenation did not improve in two of the four infants with the highest FRCs. The change in MAP needed to optimise oxygenation significantly correlated with the FRC on conventional ventilation. These data suggest that measurement of lung volume is useful to optimise oscillatory settings.
We deliberately chose to study a relatively diverse population who would be expected to have a range of lung volumes. This was for two reasons. Firstly, HFO has been shown in the clinical setting to benefit certain infants with all the diagnoses we studied and thus it was important to ensure our findings applied to these groups of patients. Secondly, the wide range of lung volumes in our patients ensures more thorough testing of the hypothesis.2 The finding that infants with the lowest lung volume required the greatest increase in MAP to optimise oxygenation would suggest that improvements in oxygenation experienced on transfer to HFO when a high volume strategy is used are due to the opening up of atelectatic lungs. Our sample size, however, was small and only a proportion of the patients received surfactant. We now plan, therefore, to study a larger cohort of infants to explore further the effect of diagnosis on the response to high volume strategy HFO.
